Nanosizing of poorly water soluble compounds using rotation/revolution mixer

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 10, 2009, Pages 1061-1067

  Takatsuka, Takayuki ^a   Endo, Tomoko ^a   Jianguo, Yao ^a   Yuminoki, Kayo ^b   Hashimoto, Naofumi ^b  

^a Thinky Corp   (Japan)

^b SETSUNAN UNIVERSITY   (Japan)

Author keywords

Milling; Mixer; Nanoparticle; Particle size; Poorly water soluble compound; Revolution

Indexed keywords

DANAZOL; INDOMETACIN; METHYLCELLULOSE; NANOPARTICLE; NAPROXEN; NIFEDIPINE; PHENYTOIN; WATER; ZIRCONIUM OXIDE;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; ELECTRON MICROSCOPE; MIXER; NANOTECHNOLOGY; PARTICLE SIZE; PULVERIZATION; ROTATION; SCANNING ELECTRON MICROSCOPY; TECHNIQUE; VESSEL; WET MILLING; X RAY DIFFRACTION;

ANTICONVULSANTS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG COMPOUNDING; METHYLCELLULOSE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; PHENYTOIN; SOLUBILITY; WATER; X-RAY DIFFRACTION;

EID: 70349655675     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.1061     Document Type: Article

References (15)

1. Yokoyama T., Yakuzaigaku, 68, 209-216 (2008).
2. Shinkuma D., Hashimoto H., Yamanaka Y., Morita Y., Acta Med. Hyogo, 1, 141-147 (1976).
3. Miyamoto K., Nou to Hattatsu, 6, 444-455 (1976).
4. Unno K., Suto I., Fukui R., Kagaya S., Nakata H., Byoin Yakugaku, 10, 323-330 (1984).
5. Yakou S., Umehara K., Sonobe T., Nagai T., Sugihara M., Fukuyama Y., Chem. Pharm. Bull., 32, 4130-4136 (1984).
6. Glazko A. J., Chang T., "Antiepileptic Drugs," ed. by Woodbury D. M., Penry J. K., Schmidt R. P., Raven Press, New York, 1972, pp. 127-136.
7. Dressman J. B., Amidon G. L., Reppas C., Shah V. P., Pharm. Res., 15, 11-22 (1998).
8. Hörter D., Dressman J. B., Adv. Drug Deliv. Rev., 46, 75-87 (2001).
9. Müller R. H., Keck C. M., J. Biotechnol., 113, 151-170 (2004).
10. Mende S., Stenger F., Peukert W., Schwedes J., Powder Technol., 132, 64-73 (2003).
11. Pongpeerapat A., Wanawongthai C., Tozuka Y., Moribe K., Yamamoto K., Int. J. Pharm., 352, 309-316 (2008).
12. Jinno J., Kamada N., Miyake M., Yamada K., Mukai T., Odomi M., Toguchi H., Liversidge G. G., Higaki K., Kimura T., J. Controlled Release, 111, 56-64 (2006).
13. Wu Y., Loper A., Landis E., Hettrick L., Novak L., Lynn K., Chen C., Thompson K., Higgins R., Batra U., Shelukar S., Kwei G., Storey D., Int. J. Pharm., 285, 135-146 (2004).
14. Niwa T., Hashimoto N., Int. J. Pharm., 350, 70-78 (2008).
15. Kano J., Miyazaki M., Saito F., Adv. Powder Technol., 11, 333-342 (2000).